Important information regarding Vyzulta

Posted in Latest News on March 16, 2018.

During the March 9, 2018 Board of Optometry meeting, the board approved for addition to Rule 64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents, Vyzulta (latanoprostene bunod ophthalmic solution) 0.024%.

Important note, Vyzulta, at this time, cannot be prescribed by licensed Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on this site, and at that time Vyzulta may be prescribed.



More Latest News

Rule 64B3-3.001
December 12, 2018

Please click here to read more information regarding the recent changes to the “General Requirements of Clinical Laboratory Personnel Training Programs.” Continue reading


Dental Sedation Workshop
December 11, 2018

Click here for more information about the Dental Sedation Workshop that will take place on February 14, 2019. Continue reading